Ardestani Ali, Tavakkoli Ali
Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
J Laparoendosc Adv Surg Tech A. 2013 Sep;23(9):760-4. doi: 10.1089/lap.2013.0012. Epub 2013 Jun 19.
Although laparoscopic splenectomy (Lap-Spleen) has become the standard surgical approach for normal-sized spleens, open splenectomy (Open-Spleen) is still recommended by many in the setting of splenomegaly. We set out to compare the impact of spleen size on Lap-Spleen and Open-Spleen outcomes using a national database.
We reviewed the American College of Surgeons' National Surgical Quality Improvement Program database to identify patients who had undergone non-emergency splenectomy during 2005-2010. To evaluate the impact of spleen size on outcomes, we considered patients with diagnoses of splenomegaly and hypersplenism as those having large spleens (Large-Sp group) and those with diagnoses of primary thrombocytopenia and immune thrombocytopenic purpura as having normal spleens (Normal-Sp group). Patients were also categorized based on surgical approach into Lap-Spleen and Open-Spleen groups.
We identified 639 patients in the Large-Sp group and 879 patients in the Normal-Sp group. During 2005-2010 laparoscopy was used in 84.2% of cases in the Normal-Sp group (annual range, 77.8%-90.8%). However, the rate of laparoscopy in the Large-Sp group remained consistently below 50% with an average of 41.8% (annual range, 20%-47%). In the Lap-Spleen group, those with Large-Sp had longer operative time and length of stay and higher blood transfusion and morbidity compared with the Normal-Sp group. However, when looking specifically at the Large-Sp group, patients with Open-Spleen had more transfusion requirements, longer length of stay, and higher morbidity, compared with those with Lap-Spleen.
Lap-Spleen leads to significant improvement in outcomes. These advantages were believed to be limited to normal-sized spleens, but this study demonstrates that laparoscopy can still be advantageous in patients with splenomegaly. We hope such data encourages wider utilization of laparoscopy in the setting of splenomegaly, especially among surgeons who are experienced with the technique.
尽管腹腔镜脾切除术(Lap - Spleen)已成为正常大小脾脏的标准手术方法,但对于脾肿大患者,许多人仍推荐开放性脾切除术(Open - Spleen)。我们利用全国性数据库比较脾脏大小对Lap - Spleen和Open - Spleen手术结果的影响。
我们回顾了美国外科医师学会国家外科质量改进计划数据库,以确定2005 - 2010年期间接受非急诊脾切除术的患者。为评估脾脏大小对手术结果的影响,我们将诊断为脾肿大和脾功能亢进的患者视为有大脾脏(大脾脏组),将诊断为原发性血小板减少症和免疫性血小板减少性紫癜的患者视为有正常脾脏(正常脾脏组)。患者还根据手术方式分为Lap - Spleen组和Open - Spleen组。
我们在大脾脏组中识别出639例患者,在正常脾脏组中识别出879例患者。在2005 - 2010年期间,正常脾脏组84.2%的病例采用了腹腔镜手术(每年范围为77.8% - 90.8%)。然而,大脾脏组的腹腔镜手术率一直低于50%,平均为41.8%(每年范围为20% - 47%)。在Lap - Spleen组中,与正常脾脏组相比,大脾脏组患者的手术时间、住院时间更长,输血率和发病率更高。然而,具体到大脾脏组,与Lap - Spleen组患者相比,Open - Spleen组患者需要更多输血,住院时间更长,发病率更高。
Lap - Spleen可显著改善手术结果。这些优势以前被认为仅限于正常大小的脾脏,但本研究表明,腹腔镜手术在脾肿大患者中仍然具有优势。我们希望这些数据能鼓励在脾肿大情况下更广泛地使用腹腔镜手术,特别是在有该技术经验的外科医生中。